iShares Nasdaq Biotechnology ETF (IBB)

Description

The investment seeks to track the performance of the ICE Biotechnology Index. The IBB ETF contains 267 constituents. It is focused on growth holdings in the North America region.

Price $117.58 as of 2022-10-20

Cost/Risk/Yield

Dividend yield0.3%
Expense ratio0.45%
Average spread0.017%
1Y roundtrip cost0.467%

Historic prices

Total Returns (including dividends)

Monthly returns heatmap

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022-13.6%-4.4%3.5%-10.5%0.0%0.8%5.5%-2.1%-3.6%0.5%-23.8%
20216.0%-2.3%-4.0%2.7%-1.7%7.7%1.3%3.9%-6.1%-1.3%-3.4%-1.0%1.9%
2020-5.6%0.1%-5.3%15.1%8.7%1.5%-1.7%0.9%-0.1%-3.5%11.0%4.5%25.6%
201913.8%2.8%-0.8%-4.8%-6.1%9.2%-3.2%-2.6%-3.3%7.9%11.5%0.8%25.2%
20186.8%-5.3%-1.2%-2.9%4.6%1.4%6.1%4.9%-0.2%-14.7%4.8%-11.6%-7.2%
20174.8%6.9%-1.2%1.5%-4.0%8.6%2.9%4.5%0.1%-5.8%0.5%1.6%20.2%
2016-21.1%-4.9%2.7%2.7%4.4%-8.0%12.5%-3.0%3.1%-11.3%6.8%-3.1%-19.1%
20156.0%4.9%1.8%-2.8%9.4%1.1%3.7%-10.6%-11.3%7.3%2.7%1.2%13.4%
20148.3%7.5%-10.6%-2.6%4.1%7.4%-2.4%10.3%-1.0%8.4%2.5%-0.2%31.6%
20136.1%1.5%8.2%7.7%4.2%-3.1%13.8%-2.1%8.2%-2.0%9.2%1.3%53.0%
201211.2%2.6%3.6%1.7%-1.7%5.6%3.0%1.9%4.8%-7.5%5.2%-1.0%29.3%
20110.3%1.0%5.8%7.3%1.8%-2.5%-2.6%-7.4%-3.0%5.2%4.0%2.1%12.1%
23.1%10.5%2.3%15.1%23.6%30.0%38.8%-1.3%-12.3%-16.8%54.8%-5.5%

Historical Dividends

Monthly dividend heatmap

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
20220.120.030.160.31
20210.130.020.120.040.32
20200.060.130.060.070.31
20190.080.070.060.21
20180.160.030.19
20170.100.060.040.120.32
20160.050.050.030.030.16
20150.020.000.010.03
20140.130.020.15
20130.020.02
20120.010.060.110.030.22
20110.000.00
0.000.000.460.000.000.770.000.000.650.000.000.37

Sectors and Top Holdings

Security % Assets
Moderna, Inc.7.96%
Amgen Inc.7.92%
Gilead Sciences, Inc.6.64%
Regeneron Pharmaceuticals, Inc.5.03%
Illumina, Inc.3.90%
IQVIA Holdings Inc3.84%
BioNTech SE Sponsored ADR3.76%
Vertex Pharmaceuticals Incorporated3.69%
Biogen Inc.3.10%
Mettler-Toledo International Inc.2.65%
Seagen, Inc.2.52%
Waters Corporation1.74%
Charles River Laboratories International, Inc.1.71%
Genmab A/S Sponsored ADR1.61%
Bio-Techne Corporation1.56%
Top 15 Weights57.63%

Compare with similar ETFs

IBB IBBQ IDNA IEIH IXJ PBE
Product nameiShares Nasdaq Biotechnology ETFInvesco Nasdaq Biotechnology ETFiShares Genomics Immunology and Healthcare ETFiShares Evolved U.S. Innovative Healthcare ETFiShares Global Healthcare ETFPowerShares Dynamic Biotechnology & Genome Portfolio ETF
IssueriSharesInvescoiSharesiSharesiSharesInvesco
Price$117.58$18.95$26.91$34.1348$76.7$59.39
Expense Ratio0.45%0%worse0.47%better0.18%better0.43%worse0.59%
Average Spread0.017%0.211%0.223%0.146%0.117%0.253%
AUM$7,490,990,000$33,791,400$184,587,000$40,743,700$3,099,990,000$226,683,000
Shares63,709,7071,783,1896,859,4061,193,61240,417,1433,816,854
Average Daily Volume1,968,1418,19254,5492,776205,3638,743
Home pageVisit external siteVisit external siteVisit external siteVisit external siteVisit external site
Inception Date2001-02-052021-06-112019-06-112018-03-212001-11-132005-06-23
Index TrackedICE Biotechnology IndexNASDAQ Biotechnology IndexNYSE FactSet Global Genomics and Immuno Biopharma IndexNo Underlying IndexS&P Global 1200 Healthcare Sector IndexDynamic Biotechnology & Genome Intellidex Index
CategoryHealth & Biotech Equitiesn/aHealth & Biotech EquitiesHealth & Biotech EquitiesHealth & Biotech EquitiesHealth & Biotech Equities
Asset ClassEquityEquityEquityEquityEquityEquity
Asset Class SizeLarge/Mid CapsLarge/Mid CapsLarge/Mid/Small CapsLarge/Mid CapsLarge CapsLarge/Mid/Small Caps
Value or GrowthGrowthBlendGrowthBlendGrowth
RegionNorth AmericaNorth AmericaNorth AmericaNorth AmericaNorth AmericaNorth America
CountriesU.S.U.S.U.S.U.S.BroadU.S.
Annual Dividend Rate$0.349$0.224$0.392$0$1.033$0
Annual Dividend Yield0.003%0.012%0.015%0.000%0.013%0.000%
Number of Holdings2672684824711530
YTD Return-22.76%-19.61%-38.29%-3.74%-14.53%-16.60%
Beta1.250.950.930.880.871.22
Upside Beta0.31-1.230.150.550.250.12
Downside Beta0.31-1.22-0.260.590.170.09
Volatility 1Y28.90%28.75%37.65%18.00%17.57%30.04%
Sharpe Ratio 3Y0.200.000.120.950.690.31
Treynor Ratio 3Y0.000.000.000.010.010.00

Historic volatility

Implied volatility

Put/Call Ratio (option volume)

Put/Call Ratio (open interest)

Volatility Spread

Volatility Skew